Nicotinamide protects target cells from cell-mediated cytolysis.
Nicotinamide in concentrations of 5 mM and greater protected fibroblast target cells from lysis by lymphokine-activated killer cells (LAK cells). Protection was concentration dependent and was exerted at the level of the target cell. Nicotinamide did not interfere with effector-target cell conjugate formation or with the calcium dependent triggering step of the lytic process. Target cell lysis in cultures without nicotinamide was accompanied by fragmentation of target cell DNA. The DNA of target cells cultured with LAK cells in the presence of nicotinamide remained intact. 3-Aminobenzamide which, like nicotinamide, inhibits poly(ADP-ribose) synthetase but is not a precursor of NAD, was an effective inhibitor of target cell lysis while nicotinic acid, an alternative precursor of NAD in cells, was not. The data point to a central role for poly(ADP-ribose) synthetase in the events leading up to DNA fragmentation and the release of 51Cr from target cells damaged by lymphokine-activated killer cells.
Hayward
A R
AR
Department of Pediatrics, University of Colorado School of Medicine, Denver 80262.
Herberger
M
M
D001549:Benzamides / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004249:DNA Damage; D006801:Humans; D066298:In Vitro Techniques; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D009243:NAD / Q000378:metabolism; D009536:Niacinamide / Q000494:pharmacology*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011971:Receptors, Immunologic / Q000378:metabolism; D015375:Receptors, Interleukin-2
D001549:Benzamides; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2; D009243:NAD; D009536:Niacinamide; C025160:3-aminobenzamide; D002118:Calcium